Docebo Inc. (DCBO) News
Follow Docebo Inc. (DCBO) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 7 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Docebo announces preliminary results of substantial issuer bid offer
Docebo announced today the preliminary results of its substantial issuer bid Offer to repurchase for cancellation, tied to the company’s closed-loop enterprise platform.
EQUITY | Sep 09, 2026, 11:00 AM UTC
M
Docebo (DCBO) amends issuer bid to repurchase up to $70M
Docebo amends its substantial issuer bid to repurchase up to $70M of common shares, raising the offer price to $25 per common share while keeping expiry at Sept 8, 2026.
MNA | Aug 21, 2026, 11:31 AM UTC
H
ManpowerGroup Posts Upbeat Q2 Earnings, Joins Docebo, Zentalis Pharmaceuticals And Other Big Stocks Moving Higher On Friday
U.S. stocks were lower, with the Nasdaq Composite falling around 400 points on Friday. Shares of ManpowerGroup Inc (NYSE: MAN ) rose sharply after the company reported upbeat second-quarter results and issued third-quart
EARNINGS | Jul 17, 2026, 02:09 PM UTC
H
Morning Movers: Netflix and Intuitive Surgical sink following quarterly results
Stock futures are lower, extending a selloff in technology shares that has weighed on the broader market despite generally solid corporate earnings and encouraging inflation data earlier in the week. The Philadelphia Sem
MACRO | Jul 17, 2026, 01:00 PM UTC
H
DCBO Docebo - RESULTS: Q2, Q2 2026 subscription REV expected at $63.5M-$63.7M, up 11.2%-11.6%, Q2 2026 total REV expected at $68.3M-$68.5M,
DCBO Docebo - RESULTS: Q2, Q2 2026 subscription REV expected at $63.5M-$63.7M, up 11.2%-11.6%, Q2 2026 total REV expected at $68.3M-$68.5M, up 12.5%-12.9%, Docebo - Earnings Notes:, Docebo Inc. announces substantial issu
RATES | Jul 17, 2026, 10:58 AM UTC
L
Docebo raises FY26 revenue view to $274.5M-$276.5M from $253.5M-$255.5M
FY26 consensus $272.08M....
EARNINGS | Jul 17, 2026, 10:40 AM UTC
H
Docebo Reports Preliminary Q2 Sales Of $68.3M-$68.5M, Up 12.5%-12.9% YoY; Announces $70M Stock Repurchase; Guides Q3 Sales $69.5M-$69.7M And
Docebo Inc. (NASDAQ: DCBO, TSX: DCBO ) ("Docebo" or the "Company"), the Enterprise Platform for the AI-era workforce, unifying skills intelligence, learning, and knowledge in one closed loop, announced that its board of
EARNINGS | Jul 17, 2026, 10:38 AM UTC